COM:SOPHIAGENETICS
Sophia Genetics
- Stock
Last Close
3.13
22/11 21:00
Market Cap
212.60M
Beta: -
Volume Today
11.62K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 3.24M - | 3.50M 7.87% | 4.56M 30.30% | 5.44M 19.44% | 5.82M 6.92% | ||
average payables | 1.29M - | 1.50M 16.67% | 1.81M 20.20% | 4.26M 135.43% | 4.22M 0.95% | ||
average receivables | 7.40M - | 8.78M 18.59% | 7.47M 14.90% | 6.87M 8.06% | 10.93M 59.08% | ||
book value per share | 0.46 - | 2.09 351.67% | 4.98 137.93% | 3.12 37.31% | 2.34 25.09% | ||
capex per share | -0.06 - | -0.07 5.64% | -0.12 80.80% | -0.16 34.25% | -0.14 12.02% | ||
capex to depreciation | -1.59 - | -1.34 15.45% | -1.85 37.88% | -1.86 0.81% | -1.11 40.61% | ||
capex to operating cash flow | 0.10 - | 0.10 5.47% | 0.12 14.02% | 0.15 28.63% | 0.19 28.24% | ||
capex to revenue | -0.12 - | -0.11 5.66% | -0.16 46.18% | -0.22 32.35% | -0.15 32.23% | ||
cash per share | 0.38 - | 2.03 428.04% | 4.80 136.67% | 2.79 41.92% | 1.90 31.69% | ||
days of inventory on hand | 174.94 - | 115.34 34.07% | 137.31 19.05% | 115.41 15.95% | 92.08 20.22% | ||
days payables outstanding | 83.79 - | 43.66 47.89% | 56.01 28.29% | 138.36 147.02% | 32.05 76.84% | ||
days sales outstanding | 139.67 - | 100.94 27.73% | 63.97 36.63% | 51.03 20.23% | 88.98 74.38% | ||
debt to assets | 0.12 - | 0.16 36.24% | 0.05 66.51% | 0.04 25.66% | 0.07 68.35% | 0.09 31.40% | |
debt to equity | 0.17 - | 0.38 126.26% | 0.07 81.04% | 0.05 34.25% | 0.08 76.43% | 0.12 46.81% | |
dividend yield | |||||||
earnings yield | -0.04 - | -0.05 16.42% | -0.09 93.31% | -0.66 600.90% | -0.26 60.90% | ||
enterprise value | -44.69M - | 795.20M 1,879.29% | 737.43M 7.26% | 599.83M 18.66% | -12.52M 102.09% | 200.33M 1,700.36% | |
enterprise value over ebitda | -26.25 - | -21.26 19.01% | -8.84 58.43% | 0.15 101.72% | -2.92 2,019.60% | ||
ev to operating cash flow | -25.10 - | -23.24 7.41% | -10.35 55.45% | 0.18 101.73% | -4.12 2,409.29% | ||
ev to sales | 31.35 - | 25.97 17.18% | 14.83 42.89% | -0.26 101.77% | 3.21 1,320.33% | ||
free cash flow per share | -0.72 - | -0.73 0.64% | -1.17 60.60% | -1.26 7.46% | -0.89 28.90% | ||
free cash flow yield | -0.04 - | -0.04 0.64% | -0.08 90.90% | -0.61 635.49% | -0.19 68.90% | ||
graham net net | -0.04 - | 1.53 3,993.40% | 4.14 170.88% | 2.22 46.26% | 1.28 42.20% | ||
graham number | 2.71 - | 6.21 129.31% | 12.22 96.71% | 9.79 19.88% | 8.01 18.16% | ||
income quality | 0.94 - | 0.77 18.30% | 0.79 2.41% | 0.80 1.53% | 0.62 23.15% | ||
intangibles to total assets | 0.11 - | 0.20 78.42% | 0.10 49.27% | 0.05 51.31% | 0.08 67.25% | 0.13 61.07% | |
interest coverage | -33.08 - | -44.24 33.74% | -108.65 145.56% | -137.44 26.50% | -130.80 4.83% | ||
interest debt per share | 0.20 - | 0.17 14.31% | 0.25 47.25% | 0.27 9.32% | 0.30 9.28% | ||
inventory turnover | 2.09 - | 3.16 51.68% | 2.66 16.00% | 3.16 18.97% | 3.96 25.34% | ||
invested capital | 0.17 - | 0.38 126.26% | 0.07 81.04% | 0.05 34.25% | 0.08 76.43% | 0.12 46.81% | |
market cap | 804.81M - | 804.81M 0% | 779.73M 3.12% | 132.04M 83.07% | 304.98M 130.97% | ||
net current asset value | 40.91M - | 4.36M 89.35% | 78.09M 1,692.27% | 238.08M 204.89% | 152.55M 35.93% | 93.33M 38.82% | |
net debt to ebitda | 0.32 - | 1.94 512.65% | 2.65 36.45% | 1.76 33.70% | 1.53 13.17% | ||
net income per share | -0.70 - | -0.82 16.42% | -1.33 62.63% | -1.36 2.40% | -1.22 10.59% | ||
operating cash flow per share | -0.66 - | -0.66 0.16% | -1.05 58.56% | -1.09 4.37% | -0.75 31.40% | ||
payables turnover | 4.36 - | 8.36 91.90% | 6.52 22.05% | 2.64 59.52% | 11.39 331.74% | ||
receivables turnover | 2.61 - | 3.62 38.37% | 5.71 57.80% | 7.15 25.36% | 4.10 42.65% | ||
research and ddevelopement to revenue | 0.59 - | 0.65 10.53% | 0.66 0.39% | 0.74 13.19% | 0.57 23.24% | ||
return on tangible assets | -0.82 - | -0.33 59.42% | -0.24 26.91% | -0.39 61.44% | -0.44 12.98% | ||
revenue per share | 0.53 - | 0.59 11.98% | 0.73 23.68% | 0.74 1.44% | 0.96 29.82% | ||
roe | -1.52 - | -0.39 74.22% | -0.27 31.65% | -0.44 63.34% | -0.52 19.35% | ||
roic | -0.92 - | -0.32 65.40% | -0.24 25.17% | -0.38 57.95% | -0.41 9.44% | ||
sales general and administrative to revenue | 0.62 - | 0.67 8.09% | 1.03 53.66% | 1.17 14.38% | 0.85 27.18% | ||
shareholders equity per share | 0.46 - | 2.09 351.67% | 4.98 137.93% | 3.12 37.31% | 2.34 25.09% | ||
stock based compensation to revenue | 0.03 - | 0.05 69.26% | 0.21 339.86% | 0.29 35.99% | 0.24 14.62% | ||
tangible asset value | 46.31M - | 12.02M 74.05% | 87.23M 625.87% | 259.73M 197.76% | 180.17M 30.63% | 124.26M 31.03% | |
tangible book value per share | 0.25 - | 1.82 625.87% | 4.70 158.56% | 2.81 40.15% | 1.92 31.73% | ||
working capital | 51.32M - | 14.50M 71.74% | 88.11M 507.55% | 254.25M 188.57% | 169.44M 33.36% | 112.43M 33.65% |
All numbers in (except ratios and percentages)